Back to Results
First PageMeta Content
Medical specialties / Ibritumomab tiuxetan / Radioimmunotherapy / Rituximab / Radiation therapy / CD20 / Nuclear medicine / Follicular lymphoma / Targeted therapy / Medicine / Lymphoma / Radiation oncology


NEOPLASIA Targeted cancer therapy with a novel low-dose rate ␣-emitting radioimmunoconjugate Jostein Dahle,1 Jørgen Borrebæk,2 Thora J. Jonasdottir,3 Anne Kristine Hjelmerud,1 Katrine B. Melhus,1 Øyvind S. Bruland,
Add to Reading List

Document Date: 2007-11-19 07:49:51

Open Document

File Size: 533,14 KB

Share Result on Facebook

City

Fullerton / Linz / Basel / Rockford / Seattle / Oslo / Carros Cedex / Berlin / /

Company

RikshospitaletRadiumhospitalet HF / Schering AG / Packard Instrument Co / NCR / Brookhaven National Laboratory / Oliver W. Press / IgG / Beckman Coulter / IDEC Pharmaceuticals / Ashmore / Becton Dickinson / F. Hoffman-LaRoche AG / Cox / Algeta ASA / Central Laboratory / /

Country

Switzerland / Norway / France / Germany / Austria / /

/

Facility

Hall EJ / Norwegian Radium Hospital / Hutchinson Cancer Research Center / Central Laboratory / /

IndustryTerm

cancer therapy / therapy of mice with lymphoma / physical and chemical properties / imaging / food / energy / treatment for follicular lymphoma / treatment of cancer / High-linear energy transfer irradiation / mL lysing solution / mean energy / Therapy of mice with Raji lymphoma / low energy transfer characteristics / particle energy / linear energy transfer / /

MedicalCondition

lymphoma cell / Clin Lymphoma / JE / B-lymphoma tumor / follicular lymphoma / nonspecific tumor / macroscopically growing tumors / lymphoma xenograft model / short-term tumor / given tumor / skeletal metastases / complete tumor / lymphoma xenografts / Leukemia / tumor / neuroblastoma meningeal carcinomatosis / cancer / tumors / Single-cell cancer / relapsed follicular non-Hodgkin lymphoma / CD20-expressing B-cell lymphoma line Raji / previously treated B-cell lymphoma / Mean tumor / RADIOIMMUNOTHERAPY OF LYMPHOMA / myelodysplasia / CD20-positive lymphoma cells / micrometastatic disease / long-term tumor / tumor shrinkage / Several tumors / lymphoma / refractory B-cell non-Hodgkin lymphoma / heterogeneous tumor / fatigue / such a tumor / macroscopic tumor / MS / Individual tumor / cancers / necrosis / macroscopic tumors / minimal disease / large tumor / non-Hodgkin’s lymphoma cells / myeloid leukemia / B-cell non-Hodgkin lymphoma / NEOPLASIA Targeted cancer / lymphoma cells / single tumor / lymphoma xenografts Figure / transformed B-cell non-Hodgkin’s lymphoma and mild thrombocytopenia / Raji tumors / Tumor volume Tumor / assessed using lymphoma cells / /

MedicalTreatment

radiotherapy / immunotherapy / Radiation / cancer therapy / radioimmunotherapy / Experimental therapy / /

MusicAlbum

J.D. / /

Organization

Institute for Transuranium Elements / National Animal Research Authority / Norwegian Radium Hospital / American Society of Hematology Introduction Monoclonal / Department of Tumor Biology / Norwegian Research council / Department of Radiation Biology / National Nuclear Data Center / Norwegian School of Veterinary Science / 5Fred Hutchinson Cancer Research Center / American Society of Hematology BLOOD / Department of Oncology / Department of Nuclear Medicine / Department of Companion Animal Clinical Sciences / the University of Michigan / /

Person

Miriam Valan / Rune Olsen / Raji / Arne Kolstad / Kari Bjering / Thomas Halvorsen / Solveig Garman-Vik / Marita Martinsen / /

Position

Fisher / /

Product

Herceptin / sevoflurane / Zevalin / anesthetized using sevoflurane / /

ProvinceOrState

Michigan / /

Technology

Radiation / apoptosis / treating cancer / alpha / antibodies / transplantation / /

URL

http /

SocialTag